Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_provenance.
- NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_assertion description "[The Seipin/BSCL2 gene was originally identified as a loss-of-function gene for congenital generalized lipodystrophy type 2 (CGL2), a condition characterized by severe lipoatrophy, insulin resistance, hypertriglyceridaemia and mental retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_provenance.
- NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_assertion evidence source_evidence_literature NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_provenance.
- NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_assertion SIO_000772 18790819 NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_provenance.
- NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_assertion wasDerivedFrom befree-20150227 NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_provenance.
- NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_assertion wasGeneratedBy ECO_0000203 NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP1007033.RAE2Djjxvhc5ryepwRsAbA6Em36g6r-RlooyuGXZ9QVj8130_provenance.